Hypotrichosis: Clinical Trials

18 trials for Hypotrichosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed. 18 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 418Completed 18

Follow Hypotrichosis: new trials by email Literature Review of Hypotrichosis trials Research Report on Hypotrichosis

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Dallixa® Eyelash Serum in Idiopathic Eyelash Hypotrichosis
dermo cosmetic product - Hypotrichosis
Phase 4CompletedQuantum Aesthetics Cosmetics372025-08-282026-11-06
Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata
Roflumilast, intralesional steroid - Alopecia, Alopecia Areata
Phase 4CompletedCairo University502025-01-122025-09-15
Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.
Apremilast 30mg - Alopecia Areata
Phase 4CompletedJinnah Postgraduate Medical Centre302022-08-012023-07-03
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
Tofacitinib - Alopecia Areata
Phase 4CompletedInstitute of Dermatology, Thailand192019-01-122022-03-31
N-Acetyl-Cysteine for Treatment of AGA in Men
Minoxidil 5% topically and oral NAC 600 mg - Androgenetic Alopecia
Phase 4CompletedKafrelsheikh University1002018-12-012025-08-27
Pain Outcomes Following Intralesional Corticosteroid Injections
Corticosteroid with lidocaine, Corticosteroid with normal saline - Keloid, Alopecia Areata
Phase 4CompletedVanderbilt University Medical Center312018-10-012021-03-11
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
Triamcinolone Acetonide, Minoxidil 5 % Topical Spray, clobetasol propionate - Alopecia Areata
Phase 4CompletedCairo University402016-03-012018-05-24
Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
Topical latanoprost 0.005%, Topical betamethasone 0.05% - Alopecia Areata
Phase 4CompletedPost Graduate Institute of Medical Education and Research, Chandigarh502014-09-012015-12-02
Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows
Track A, Track B - Hypotrichosis
Phase 4CompletedATS Clinical Research332013-05-012015-01-14
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
bimatoprost ophthalmic solution 0.03%, bimatoprost vehicle solution - Hypotrichosis
Phase 4CompletedAllergan882011-10-012013-05-22
Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
topical bimatoprost - Hypotrichosis
Phase 4CompletedKenneth Beer202011-03-012012-06-15
Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
bimatoprost ophthalmic solution 0.03%, Vehicle Sterile Solution - Eyelash Hypotrichosis, Alopecia Areata
Phase 4CompletedAllergan712010-06-012019-04-17
Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis
bimatoprost ophthalmic 0.03% solution, vehicle sterile solution (placebo) - Hypotrichosis
Phase 4CompletedAllergan892009-11-012012-01-05
Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
methylprednisolone sodium succinate - Alopecia Totalis, Alopecia Universalis
Phase 4CompletedKing Saud University422003-01-012010-07-22
Plaquenil for Alopecia Areata, Alopecia Totalis
Hydroxychloroquine - Alopecia Areata
Phase 4CompletedHordinsky, Maria K., MD162002-04-012009-08-13
Aldara for the Treatment of Extensive Alopecia Areata
Aldara Cream 5% - Alopecia Areata
Phase 4CompletedHordinsky, Maria K., MD202000-10-012006-11-13
Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%
Aldara Cream 5% - Alopecia Areata
Phase 4CompletedHordinsky, Maria K., MD202000-10-012014-02-14
Response of Topical Capsaicin in Alopecia Areata
Capsaicin - Alopecia Areata
Phase 4CompletedUniversity of Minnesota241997-08-012014-06-02

Narrower conditions

Alopecia Areata (12)  ·  Alopecia (2)  ·  Alopecia universalis (2)  ·  Acne Vulgaris (1)  ·  Cicatrix, Hypertrophic (1)  ·  Dermoid Cyst (1)  ·  Granuloma Annulare (1)  ·  Keloid (1)  ·  Keratoacanthoma (1)  ·  Lichen Planus (1)  ·  Lymphoma, Follicular (1)  ·  Neurodermatitis (1)  ·  Scleroderma, Localized (1)

Broader conditions

Hair Diseases (18)  ·  Skin Diseases (18)  ·  Skin and Connective Tissue Diseases (18)  ·  Alopecia (11)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathological Conditions, Anatomical (2)  ·  Acneiform Eruptions (1)  ·  Cicatrix (1)  ·  Collagen Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Cysts (1)  ·  Dermatitis (1)

Interventions

Bimatoprost (5)  ·  Minoxidil (2)  ·  Solutions (2)  ·  Adrenal Cortex Hormones (1)  ·  Capsaicin (1)  ·  Clobetasol (1)  ·  Hydroxychloroquine (1)  ·  Lidocaine (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Roflumilast (1)  ·  Saline Solution (1)  ·  Triamcinolone Acetonide (1)  ·  apremilast (1)  ·  tofacitinib (1)

Sponsors

Allergan (3)  ·  Hordinsky, Maria K., MD (3)  ·  Cairo University (2)  ·  ATS Clinical Research (1)  ·  Institute of Dermatology, Thailand (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Kafrelsheikh University (1)  ·  Kenneth Beer (1)  ·  King Saud University (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Quantum Aesthetics Cosmetics (1)  ·  University of Minnesota (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (10)  ·  Egypt (2)  ·  Brazil (1)  ·  India (1)  ·  Pakistan (1)  ·  Saudi Arabia (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)

Top investigators

Maria Hordinsky, MD (4)  ·  Marna Ericson, Ph D (2)  ·  Ava Shamban, MD (1)  ·  Brian Drolet, MD (1)  ·  Chinmanat Lekhavat, MD (1)  ·  Faiza Inam, FCPS (1)  ·  Ghada A Binsaif, MD (1)  ·  Heba M Mashaly, MD (1)  ·  Kenneth Beer, M.D. (1)  ·  Khadija Asadullah, FCPS (1)  ·  Mahira H El Sayed, Professor (1)  ·  Marna Ericson, PhD (1)  ·  Mona MI ElKalioby, MD (1)  ·  Nazia Jabeen, FCPS (1)

Results publications

PMID 20115945, PMID 20384750, PMID 20384751, PMID 33580923, PMID 33760691